https://www.zacks.com/stock/news/2210358/will-zoetis-zts-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2210358
Jan 15, 2024 - Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:599458842155851651
0
https://www.zacks.com/stock/news/2217316/grfs-or-zts-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2217316
Jan 29, 2024 - GRFS vs. ZTS: Which Stock Is the Better Value Option?
zc:6035231730213846159
0
https://www.zacks.com/stock/news/2221862/zoetis-zts-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2221862
Feb 06, 2024 - Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-133087716661103603
0
https://www.zacks.com/stock/news/2225640/zoetis-zts-q4-earnings-miss-expectations-sales-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2225640
Feb 13, 2024 - Zoetis (ZTS) reports mixed fourth-quarter results, wherein earnings miss estimates while revenues beat the same.
zc:7077486771379199032
0
https://www.zacks.com/stock/news/2226324/grfs-or-zts-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2226324
Feb 14, 2024 - GRFS vs. ZTS: Which Stock Is the Better Value Option?
zc:3681941353378489616
0
https://www.zacks.com/stock/news/2226118/company-news-for-feb-14-2024?cid=CS-ZC-FT-corporate_summary-2226118
Feb 14, 2024 - Companies in The News Are: ZTS,MAR,ECL,HAS
zc:-6820200728142035015
0
https://www.zacks.com/stock/news/2259683/zoetis-zts-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2259683
Apr 22, 2024 - In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day.
zc:3251859914440260972
0
https://www.zacks.com/stock/news/2264204/biocryst-pharmaceuticals-bcrx-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2264204
Apr 29, 2024 - BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-7296357317551134025
0